HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

W B Knight Selected Research

Proteins (Proteins, Gene)

10/2001The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


W B Knight Research Topics

Disease

2Neoplasms (Cancer)
12/2001 - 10/2001

Drug/Important Bio-Agent (IBA)

2Phosphotransferases (Kinase)IBA
12/2001 - 10/2001
2Tyrosine Kinase InhibitorsIBA
12/2001 - 10/2001
1ErbB Receptors (EGF Receptor)IBA
12/2001
1N- (3- chloro- 4- ((3- fluorobenzyl)oxy)phenyl- 6- (5- ((methylsulfonyl)ethyl)aminomethyl)- 2- furyl)- 4- quinazolinamineIBA
12/2001
1Tyrosine (L-Tyrosine)FDA Link
12/2001
1tyrosine receptor (receptor, tyrosine)IBA
10/2001
1Proteins (Proteins, Gene)FDA Link
10/2001

Therapy/Procedure

2Therapeutics
12/2001 - 10/2001